BDMD

Baird Medical Investment Holdings Ltd Ordinary Share

5.29 USD
+0.67
14.50%
At close Mar 12, 4:00 PM EDT
After hours
5.40
+0.11
2.08%
1 day
14.50%
5 days
39.21%
1 month
-10.49%
3 months
239.10%
6 months
-11.83%
Year to date
3.32%
1 year
-11.83%
5 years
-11.83%
10 years
-11.83%
 

About: Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

0
Funds holding %
of 7,363 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

0.86% more ownership

Funds ownership: 0% [Q3] → 0.86% (+0.86%) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for BDMD.

Financial journalist opinion

Based on 3 articles about BDMD published over the past 30 days

Neutral
PRNewsWire
2 days ago
Baird Medical Secures Indonesian Regulatory Approval for Microwave Ablation Technology
NEW YORK , March 10, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a global leader in microwave ablation (MWA) technology, has received regulatory approval from the Indonesian Ministry of Health (Kementerian Kesehatan Republik Indonesia).
Baird Medical Secures Indonesian Regulatory Approval for Microwave Ablation Technology
Neutral
PRNewsWire
1 week ago
Baird Medical Showcases Cutting-Edge MWA Innovations at NASOIE 2025
NEW YORK , March 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a global leader in microwave ablation (MWA) technology, made a lasting impact at the 2025 North American Society of Interventional Endocrinologists (NASOIE) Annual Meeting in Lehi, Utah.
Baird Medical Showcases Cutting-Edge MWA Innovations at NASOIE 2025
Neutral
PRNewsWire
2 weeks ago
Baird Medical Expands Global MWA Training with Expert-Led Program in Guangzhou
NEW YORK , Feb. 26, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a leading innovator in microwave ablation (MWA) technology, continues to strengthen international medical collaboration.
Baird Medical Expands Global MWA Training with Expert-Led Program in Guangzhou
Neutral
PRNewsWire
1 month ago
Baird Medical Advances MWA Training with Expert-Led Course at Columbia Thyroid Center
NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, remains committed to advancing physician education and recently supported Dr. Hosai Todd-Hesham's participation in a specialized MWA training program at the Columbia Thyroid Center in New York City.
Baird Medical Advances MWA Training with Expert-Led Course at Columbia Thyroid Center
Neutral
PRNewsWire
1 month ago
Baird Medical Showcases Groundbreaking MWA Innovations at NASIT 2025
NEW YORK , Feb. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, made a significant impact at the 2025 North American Society for Interventional Thyroidology (NASIT) conference.
Baird Medical Showcases Groundbreaking MWA Innovations at NASIT 2025
Neutral
PRNewsWire
1 month ago
Baird Medical Shines at 2025 Microcap Conference: Driving Growth Through Technological Innovation and Strategic Collaborations
NEW YORK , Jan. 30, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, today announced its successful participation in the 2025 Microcap Conference, held at the Borgata Hotel in Atlantic City, New Jersey.
Baird Medical Shines at 2025 Microcap Conference: Driving Growth Through Technological Innovation and Strategic Collaborations
Neutral
PRNewsWire
1 month ago
Baird Medical Celebrates 2024 Breakthroughs and Accolades, Forging a New Era in Minimally Invasive MWA Technology
NEW YORK , Jan. 27, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, reflects on a landmark year of innovation and achievement.
Baird Medical Celebrates 2024 Breakthroughs and Accolades, Forging a New Era in Minimally Invasive MWA Technology
Neutral
PRNewsWire
1 month ago
Baird Medical to Participate in NASIT 2025 Conference
NEW YORK , Jan. 24, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 2025 North American Society for Interventional Thyroidology (NASIT) Conference, taking place January 31 – February 1, 2025, in Washington, D.C.
Baird Medical to Participate in NASIT 2025 Conference
Neutral
PRNewsWire
1 month ago
Baird Medical to Attend Microcap Conference at Borgata Hotel
NEW YORK , Jan. 23, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation technology (MWA), announced today that it will participate in the highly anticipated Microcap Conference, set to take place at the Borgata Hotel in Atlantic City, New Jersey, from January 28 to January 30, 2025.
Baird Medical to Attend Microcap Conference at Borgata Hotel
Neutral
PRNewsWire
1 month ago
Baird Medical Expands into San Francisco, Advancing U.S. Market Growth
NEW YORK , Jan. 22, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, is expanding its presence into San Francisco, marking an important step in its U.S. growth strategy.
Baird Medical Expands into San Francisco, Advancing U.S. Market Growth
Charts implemented using Lightweight Charts™